You have 9 free searches left this month | for more free features.

IDH-mutated diffuse grade III astrocytoma

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Oligodendroglioma, Oligodendroglioma, Anaplastic, Diffuse Astrocytoma, IDH-Mutant Trial in Oslo (Radiation therapy)

Recruiting
  • Oligodendroglioma
  • +2 more
  • Radiation therapy
  • Oslo, Norway
    Oslo University Hospital
Jan 14, 2022

Astrocytoma, IDH-Mutant, Grade 2, Astrocytoma, IDH-Mutant, Grade 3 Trial in United States (other, radiation, drug)

Active, not recruiting
  • Astrocytoma, IDH-Mutant, Grade 2
  • Astrocytoma, IDH-Mutant, Grade 3
  • Questionnaire Administration
  • +3 more
  • Phoenix, Arizona
  • +24 more
Dec 7, 2022

Grade III Astrocytoma, Grade IV Astrocytoma, Astrocytoma, Grade IV Trial in Saint Louis (Tadalafil)

Active, not recruiting
  • Grade III Astrocytoma
  • +3 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jun 9, 2022

Anaplastic Astrocytoma, IDH-Wildtype, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Houston (other,

Recruiting
  • Anaplastic Astrocytoma, IDH-Wildtype
  • +8 more
  • Quality-of-Life Assessment
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 8, 2022

Astrocytoma, Glioblastoma Trial in Spain, United States (CC-90010)

Active, not recruiting
  • Astrocytoma
  • Glioblastoma
  • Jacksonville, Florida
  • +8 more
Dec 14, 2022

Supramaximal Resection Versus Maximal Resection for High-Grade

Recruiting
  • Glioblastoma
  • +11 more
  • Supramaximal resection
  • Maximal safe resection
  • San Francisco, California
  • +7 more
Nov 1, 2023

Targeted Pediatric High-Grade Glioma Therapy

Not yet recruiting
  • High Grade Glioma
  • +8 more
    • Aurora, Colorado
    • +17 more
    May 1, 2023

    Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype, Astrocytoma, Grade III Trial in San Antonio, Zuerich (Debio 0123,

    Not yet recruiting
    • Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype
    • Astrocytoma, Grade III
    • Debio 0123
    • +2 more
    • San Antonio, Texas
    • +1 more
    Mar 9, 2023

    Radiotherapy in IDH Mutated Glioma: Evaluation of Late Outcomes

    Recruiting
    • Astrocytoma, Grade II
    • +3 more
      • Rotterdam, Zuid Holland, Netherlands
      • +4 more
      Mar 23, 2020

      Low-grade Glioma, Temozolomide, Phase III Trial in Worldwide (drug, radiation, procedure)

      Terminated
      • Low-grade Glioma
      • +3 more
      • Woolloongabba, Brisbane, QLD, Australia
      • +44 more
      Jan 31, 2022

      Foci of Tumor Heterogeneity in Diffuse Low-Grade Gliomas

      Completed
      • Glioma
        • Montpellier, France
          Uh Montpellier
        Jun 4, 2020

        Space Occupying Lesions of the Brain

        Recruiting
        • Brain Tumor
        • +2 more
        • MR-scans using a 3T Prisma and a 7T Terra scanner (Siemens, Erlangen Germany)
        • Bern, Switzerland
          Institute for Diagnostic and Interventional Neuroradiology, Univ
        Jan 26, 2023

        Recurrent IDH1/2 Mutated Glioma Trial in Paris (Azacitidine)

        Recruiting
        • Recurrent IDH1/2 Mutated Glioma
        • Paris, France
          Pitie Salpetriere Hospital
        Aug 29, 2022

        Glioma Trial in Melbourne (Biopsy, Part A: AB-218, Surgery (maximal resection))

        Recruiting
        • Glioma
        • Biopsy
        • +3 more
        • Melbourne, Victoria, Australia
          Royal Melbourne Hospital
        Oct 11, 2022

        Clinical Development of Cancer-Specific MRS Biomarkers in

        Completed
        • Malignant Gliomas
        • +2 more
        • 3 Tesla scanning
        • Dallas, Texas
          UT Southwestern Medical Center
        Jan 19, 2022

        Vascular Habitats Within Astrocytoma Grade 4 at Molecular,

        Recruiting
        • Astrocytoma, Grade IV
        • +7 more
          • Valencia, Spain
            Biomedical Data Science Lab. Universitat Politècnica de València
          May 11, 2022

          High Grade Glioma, Brain Cancer Trial in France (Nivolumab)

          Completed
          • High Grade Glioma
          • Brain Cancer
          • Bordeaux, France
          • +6 more
          Dec 13, 2021

          Glioma Trial in Paris (MRI)

          Not yet recruiting
          • Glioma
          • MRI
          • Paris, France
            Pitié-Salpetrière Hospital
          Jan 27, 2023

          Diffuse Intrinsic Pontine Glioma, Recurrent Anaplastic Astrocytoma, Recurrent Glioblastoma Trial in Switzerland, United States

          Active, not recruiting
          • Diffuse Intrinsic Pontine Glioma
          • +4 more
          • Los Angeles, California
          • +18 more
          Aug 16, 2022

          Diffuse Astrocytoma, IDH-Mutant, Glioblastoma, IDH-wildtype, Brain Metastases, Adult Trial (NEO212 Oral Capsule, Ipilimumab,

          Not yet recruiting
          • Diffuse Astrocytoma, IDH-Mutant
          • +20 more
          • NEO212 Oral Capsule
          • +8 more
          • (no location specified)
          Sep 18, 2023

          Astrocytoma, Grade III Trial in Orange (NOVOTTF-200A)

          Recruiting
          • Astrocytoma, Grade III
          • NOVOTTF-200A
          • Orange, California
            University of California, Irvine
          Feb 19, 2021

          Glioma of Brain Trial in Bern, Lausanne, Zürich (L19TNF)

          Active, not recruiting
          • Glioma of Brain
          • Bern, Switzerland
          • +2 more
          Apr 7, 2022

          Diffuse Intrinsic Pontine Glioma, Anaplastic Astrocytoma, High Grade Glioma Trial run by the NCI (Lenalidomide, XRT, 54-59.4 Gy)

          Completed
          • Diffuse Intrinsic Pontine Glioma
          • +2 more
          • Bethesda, Maryland
            National Institutes of Health Clinical Center, 9000 Rockville Pi
          Dec 30, 2021

          Oligodendroglioma, Astrocytoma, Grade II, Glioma, Astrocytic Trial in San Francisco (GBM6-AD and poly-ICLC before and after

          Active, not recruiting
          • Oligodendroglioma
          • +5 more
          • GBM6-AD and poly-ICLC before and after surgery
          • GBM6-AD and poly-ICLC after surgery only
          • San Francisco, California
            University of California
          Sep 20, 2022